using the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" uses

Questions are coming up about using the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" uses.

All are approved to prevent stroke in nonvalvular atrial fib.

Xarelto (rivaroxaban) is also approved to prevent thrombosis after hip or knee surgery...or to treat venous thromboembolism.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote